Goldman Sachs’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,590,091
Closed -$64.6M 4667
2020
Q2
$64.6M Buy
3,590,091
+2,306,912
+180% +$41.5M 0.02% 698
2020
Q1
$9.15M Buy
1,283,179
+685,231
+115% +$4.89M ﹤0.01% 1850
2019
Q4
$14.3M Sell
597,948
-499,829
-46% -$11.9M ﹤0.01% 1832
2019
Q3
$29.4M Buy
1,097,777
+331,724
+43% +$8.9M 0.01% 1305
2019
Q2
$20.8M Sell
766,053
-42,759
-5% -$1.16M 0.01% 1560
2019
Q1
$28.1M Buy
808,812
+238,890
+42% +$8.29M 0.01% 1377
2018
Q4
$11.1M Buy
569,922
+91,576
+19% +$1.79M ﹤0.01% 1879
2018
Q3
$12.7M Buy
478,346
+58,414
+14% +$1.56M ﹤0.01% 1910
2018
Q2
$15.9M Sell
419,932
-36,439
-8% -$1.38M ﹤0.01% 1767
2018
Q1
$14.9M Buy
456,371
+93,739
+26% +$3.06M ﹤0.01% 1718
2017
Q4
$17.7M Sell
362,632
-69,676
-16% -$3.39M ﹤0.01% 1616
2017
Q3
$23.4M Sell
432,308
-255,784
-37% -$13.8M 0.01% 1492
2017
Q2
$38.7M Buy
688,092
+171,046
+33% +$9.61M 0.01% 1174
2017
Q1
$20.3M Buy
517,046
+350,240
+210% +$13.7M 0.01% 1507
2016
Q4
$3.74M Sell
166,806
-662,048
-80% -$14.9M ﹤0.01% 2355
2016
Q3
$18.8M Buy
828,854
+701,548
+551% +$15.9M 0.01% 1502
2016
Q2
$3M Buy
127,306
+2,460
+2% +$58K ﹤0.01% 2385
2016
Q1
$2.55M Buy
124,846
+57,307
+85% +$1.17M ﹤0.01% 2399
2015
Q4
$3.48M Sell
67,539
-26,381
-28% -$1.36M ﹤0.01% 2244
2015
Q3
$4M Buy
93,920
+68,845
+275% +$2.93M ﹤0.01% 2138
2015
Q2
$1.14M Buy
25,075
+18,250
+267% +$831K ﹤0.01% 2891
2015
Q1
$259K Sell
6,825
-11,588
-63% -$440K ﹤0.01% 3735
2014
Q4
$521K Buy
+18,413
New +$521K ﹤0.01% 3343
2014
Q3
Sell
-12,635
Closed -$369K 4651
2014
Q2
$369K Sell
12,635
-3,224
-20% -$94.2K ﹤0.01% 3541
2014
Q1
$411K Sell
15,859
-18,967
-54% -$492K ﹤0.01% 3485
2013
Q4
$897K Sell
34,826
-179,399
-84% -$4.62M ﹤0.01% 3123
2013
Q3
$5.73M Sell
214,225
-1
-0% -$27 ﹤0.01% 1815
2013
Q2
$5.26M Buy
+214,226
New +$5.26M ﹤0.01% 1733